An assessment of downward trends in neurodevelopmental disorders in the United States following removal of Thimerosal from childhood vaccines.
BACKGROUND
The US is in the midst of an epidemic of neurodevelopmental disorders (NDs). Thimerosal is an ethylmercury-containing compound added to some childhood vaccines. Several previous epidemiological studies conducted in the US have associated Thimerosal-containing vaccine (TCV) administration with NDs.


METHODS
An ecological study was undertaken to evaluate NDs reported to the Vaccine Adverse Event Reporting System (VAERS) from 1991 through 2004 by date of receipt and by date of vaccine administration. The NDs examined included autism, mental retardation, and speech disorders. Statistical trend analysis was employed to evaluate the effects of removal of Thimerosal on the proportion of NDs reported to VAERS.


RESULTS
There was a peak in the proportion of ND reports received by VAERS in 2001-2002 and in the proportion of ND reports by date of vaccine administration in 1998. There were significant reductions in the proportion of NDs reported to VAERS as Thimerosal was begun to be removed from childhood vaccines in the US from mid-1999 onwards.


CONCLUSIONS
The present study provides the first epidemiological evidence showing that as Thimerosal was removed from childhood vaccines, the number of NDs has decreased in the US. The analysis techniques utilized attempted to minimize chance or bias/confounding. Additional research should be conducted to further evaluate the relationship between TCVs and NDs. This is especially true because the handling of vaccine safety data from the National Immunization Program of the CDC has been called into question by the Institute of Medicine of the National Academy of Sciences in 2005.
Geier
David A
DA
Department of Biochemistry, George Washington University, Washington, DC, USA.
Geier
Mark R
MR
D002659:Child Development Disorders, Pervasive / Q000453:epidemiology*; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D011310:Preservatives, Pharmaceutical / Q000633:toxicity*; D013849:Thimerosal / Q000633:toxicity*; D014481:United States; D014612:Vaccines / Q000009:adverse effects*
D011310:Preservatives, Pharmaceutical; D014612:Vaccines; D013849:Thimerosal